Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HBeAg-positive Chronic Hepatitis B”

127 trials

Showing 20 of 127 results

Post-approval studies (Phase 4)Study completedNCT00487747
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 18
Testing effectiveness (Phase 2)UnknownNCT04157699
What this trial is testing

Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b

Who this might be right for
Chronic Hepatitis b
Qilu Pharmaceutical Co., Ltd. 100
Early research (Phase 1)Study completedNCT02401737
What this trial is testing

Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

Who this might be right for
Chronic Hepatitis B
Novira Therapeutics, Inc. 58
Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing

Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39
Post-approval studies (Phase 4)Study completedNCT00537537
What this trial is testing

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Ended earlyNCT00496002
What this trial is testing

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus

Who this might be right for
Chronic HepatitisHepatitis B
Pharmasset
Post-approval studies (Phase 4)UnknownNCT01456312
What this trial is testing

HBsAg Related Response Guided Therapy

Who this might be right for
Hepatitis B, Chronic
Gangnam Severance Hospital 200
Large-scale testing (Phase 3)Study completedNCT00857675
What this trial is testing

A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 480
Post-approval studies (Phase 4)UnknownNCT02973646
What this trial is testing

Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 100
Large-scale testing (Phase 3)Study completedNCT01760122
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 820
Large-scale testing (Phase 3)Study completedNCT01079806
What this trial is testing

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B Virus, Pediatric
Bristol-Myers Squibb 180
Post-approval studies (Phase 4)Study completedNCT02598063
What this trial is testing

Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 255
Post-approval studies (Phase 4)Study completedNCT02604823
What this trial is testing

Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 307
Not applicableUnknownNCT04650828
What this trial is testing

TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Large-scale testing (Phase 3)UnknownNCT01220596
What this trial is testing

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hanyang University 228
Early research (Phase 1)Study completedNCT00962871
What this trial is testing

Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 30
Not applicableStudy completedNCT02387463
What this trial is testing

Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 160
Testing effectiveness (Phase 2)Ended earlyNCT02604212
What this trial is testing

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 32
Large-scale testing (Phase 3)Ended earlyNCT00376259
What this trial is testing

Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

Who this might be right for
Hepatitis B
Novartis 43
Not applicableStudy completedNCT01311947
What this trial is testing

Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
China Medical University Hospital 103
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation